Federal award
GEN-PROBE INCORPORATED
W81K0020P0322
Contract
Obligated and Ceiling
- Obligated (net)
- $504,654.00
- Ceiling (potential value, not spending)
- $504,654.00
- Current value
- $504,654.00
- Gross positive obligations
- $1,153,200.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- GEN-PROBE INCORPORATED · QNXWLAJDL4J3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GEN-PROBE INCORPORATED · C5NDR1H6DJY4
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0020P0322
- Award type code
- B
- Actions
- 8 · Sep 15, 2020 to Feb 6, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 6, 2023 | FY2023 | P00007 | K | −$71,448.00 | — |
| Jul 25, 2022 | FY2022 | P00006 | C | −$259,968.00 | — |
| Oct 18, 2021 | FY2022 | P00005 | C | $576,600.00 | — |
| Jul 30, 2021 | FY2021 | P00004 | C | −$317,130.00 | — |
| Apr 27, 2021 | FY2021 | P00003 | B | $0.00 | — |
| Apr 21, 2021 | FY2021 | P00002 | G | $0.00 | — |
| Oct 16, 2020 | FY2021 | P00001 | C | $576,600.00 | — |
| Sep 15, 2020 | FY2020 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.